Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO DIFFERENT BOUND LIGANDS
 
Authors :  S. J. Everse, G. Spraggon, L. Veerapandian, M. Riley, R. F. Doolittle
Date :  19 May 98  (Deposition) - 14 Oct 98  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.30
Chains :  Asym./Biol. Unit :  A,B,C,D,E,F,G,H,I,J
Keywords :  Blood Coagulation, Plasma Protein, Crosslinking (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  S. J. Everse, G. Spraggon, L. Veerapandian, M. Riley, R. F. Doolittle
Crystal Structure Of Fragment Double-D From Human Fibrin With Two Different Bound Ligands.
Biochemistry V. 37 8637 1998
PubMed-ID: 9628725  |  Reference-DOI: 10.1021/BI9804129
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - FIBRIN
    ChainsA, D
    FragmentDOUBLE-D
    OrganBLOOD
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    TissueBLOOD
 
Molecule 2 - FIBRIN
    ChainsB, E
    FragmentDOUBLE-D
    OrganBLOOD
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    TissueBLOOD
 
Molecule 3 - FIBRIN
    ChainsC, F
    FragmentDOUBLE-D
    OrganBLOOD
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    TissueBLOOD
 
Molecule 4 - FIBRIN
    ChainsG, H
    FragmentDOUBLE-D
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    TissueBLOOD
 
Molecule 5 - FIBRIN
    ChainsI, J
    FragmentDOUBLE-D
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    TissueBLOOD

 Structural Features

(-) Chains, Units

  12345678910
Asymmetric/Biological Unit ABCDEFGHIJ

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (3, 9)

Asymmetric/Biological Unit (3, 9)
No.NameCountTypeFull Name
1CA4Ligand/IonCALCIUM ION
2MAN1Ligand/IonALPHA-D-MANNOSE
3NAG4Ligand/IonN-ACETYL-D-GLUCOSAMINE

(-) Sites  (9, 9)

Asymmetric Unit (9, 9)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREASN B:364 , HIS I:2 , NAG I:471BINDING SITE FOR RESIDUE NAG B 470
2AC2SOFTWARENAG B:470 , MAN B:472BINDING SITE FOR RESIDUE NAG I 471
3AC3SOFTWARENAG I:471BINDING SITE FOR RESIDUE MAN B 472
4AC4SOFTWAREASN E:364 , HIS J:2 , NAG J:471BINDING SITE FOR RESIDUE NAG E 470
5AC5SOFTWARENAG E:470BINDING SITE FOR RESIDUE NAG J 471
6AC6SOFTWAREASP B:381 , ASP B:383 , TRP B:385 , HOH B:570 , HOH B:595BINDING SITE FOR RESIDUE CA B 2
7AC7SOFTWAREASP C:318 , ASP C:320 , PHE C:322 , GLY C:324BINDING SITE FOR RESIDUE CA C 1
8AC8SOFTWAREASP E:381 , ASP E:383 , TRP E:385 , HOH E:475 , HOH E:517BINDING SITE FOR RESIDUE CA E 2
9AC9SOFTWAREASP F:318 , ASP F:320 , PHE F:322 , GLY F:324 , HOH F:475BINDING SITE FOR RESIDUE CA F 1

(-) SS Bonds  (16, 16)

Asymmetric/Biological Unit
No.Residues
1A:161 -C:135
2A:165 -B:193
3B:197 -C:139
4B:201 -B:286
5B:211 -B:240
6B:394 -B:407
7C:153 -C:182
8C:326 -C:339
9D:161 -F:135
10D:165 -E:193
11E:197 -F:139
12E:201 -E:286
13E:211 -E:240
14E:394 -E:407
15F:153 -F:182
16F:326 -F:339

(-) Cis Peptide Bonds  (4, 4)

Asymmetric/Biological Unit
No.Residues
1Arg B:406 -Cys B:407
2Lys C:338 -Cys C:339
3Arg E:406 -Cys E:407
4Lys F:338 -Cys F:339

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (31, 62)

Asymmetric/Biological Unit (31, 62)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_033930Y140HFIBG_HUMANPolymorphism2066870C/FY114H
02UniProtVAR_002399R160SFIBA_HUMANUnclassified  ---A/DR141S
03UniProtVAR_014170G191RFIBG_HUMANPolymorphism6063C/FG165R
04UniProtVAR_072723C184WFIBA_HUMANDisease (CAFBN)  ---A/DC165W
05UniProtVAR_016908R196CFIBB_HUMANDisease (CAFBN)121909623B/ER166C
06UniProtVAR_072620L202QFIBB_HUMANDisease (CAFBN)121909624B/EL172Q
07UniProtVAR_013093P265LFIBB_HUMANPolymorphism6054B/EP235L
08UniProtVAR_002409R301CFIBG_HUMANPolymorphism121913087C/FR275C
09UniProtVAR_002410R301HFIBG_HUMANDisease (DYSFIBRIN)121913088C/FR275H
10UniProtVAR_072726T303PFIBG_HUMANDisease (CAFBN)  ---C/FT277P
11UniProtVAR_002411G318VFIBG_HUMANDisease (DYSFIBRIN)121913089C/FG292V
12UniProtVAR_072727D327HFIBG_HUMANDisease (CAFBN)  ---C/FD301H
13UniProtVAR_002413N334IFIBG_HUMANPolymorphism121913090C/FN308I
14UniProtVAR_002412N334KFIBG_HUMANUnclassified  ---C/FN308K
15UniProtVAR_015853G335DFIBG_HUMANUnclassified  ---C/FG309D
16UniProtVAR_002414M336TFIBG_HUMANPolymorphism121913091C/FM310T
17UniProtVAR_072728N345DFIBG_HUMANDisease (CAFBN)  ---C/FN319D
18UniProtVAR_002416Q355RFIBG_HUMANPolymorphism121913092C/FQ329R
19UniProtVAR_002418D356VFIBG_HUMANDisease (DYSFIBRIN)121913094C/FD330V
20UniProtVAR_002417D356YFIBG_HUMANPolymorphism121913093C/FD330Y
21UniProtVAR_002407A365TFIBB_HUMANPolymorphism121909617B/EA335T
22UniProtVAR_002419N363KFIBG_HUMANUnclassified  ---C/FN337K
23UniProtVAR_016909L383RFIBB_HUMANDisease (CAFBN)121909621B/EL353R
24UniProtVAR_002421S384CFIBG_HUMANUnclassified  ---C/FS358C
25UniProtVAR_002422R401GFIBG_HUMANPolymorphism75848804C/FR375G
26UniProtVAR_072729R401WFIBG_HUMANDisease (CAFBN)75848804C/FR375W
27UniProtVAR_072725T407KFIBB_HUMANDisease (CAFBN)  ---B/ET377K
28UniProtVAR_072621S404PFIBG_HUMANDisease (DYSFIBRIN)587777720C/FS378P
29UniProtVAR_014171M410VFIBG_HUMANPolymorphism6061C/FM384V
30UniProtVAR_016910G430DFIBB_HUMANDisease (CAFBN)121909622B/EG400D
31UniProtVAR_002408R478KFIBB_HUMANPolymorphism4220B/ER448K

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 8)

Asymmetric/Biological Unit (2, 8)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1FIBRINOGEN_C_2PS51406 Fibrinogen C-terminal domain profile.FIBG_HUMAN170-416
 
  2C:144-390
F:144-390
FIBB_HUMAN232-488
 
  2B:202-458
E:202-458
2FIBRINOGEN_C_1PS00514 Fibrinogen C-terminal domain signature.FIBG_HUMAN360-372
 
  2C:334-346
F:334-346
FIBB_HUMAN432-444
 
  2B:402-414
E:402-414

(-) Exons   (13, 26)

Asymmetric/Biological Unit (13, 26)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003020531aENSE00001909776chr4:155511918-155511786133FIBA_HUMAN1-18180--
1.2ENST000003020532ENSE00001127292chr4:155510714-155510589126FIBA_HUMAN19-60420--
1.3ENST000003020533ENSE00001127283chr4:155510128-155509945184FIBA_HUMAN61-122620--
1.4bENST000003020534bENSE00001127274chr4:155508809-155508664146FIBA_HUMAN122-170492A:119-151
D:119-151
33
33
1.5bENST000003020535bENSE00001127263chr4:155508070-1555066901381FIBA_HUMAN171-6314612A:152-192
D:152-192
41
41
1.6ENST000003020536ENSE00001210975chr4:155505985-1555042781708FIBA_HUMAN631-8662360--

2.1aENST000003020681aENSE00001171218chr4:155484108-155484284177FIBB_HUMAN1-38380--
2.2dENST000003020682dENSE00001640255chr4:155486960-155487151192FIBB_HUMAN39-102640--
2.3bENST000003020683bENSE00001645081chr4:155487641-155487824184FIBB_HUMAN103-164620--
2.4bENST000003020684bENSE00001127321chr4:155488745-155488972228FIBB_HUMAN164-240772B:151-210
E:151-210
60
60
2.5ENST000003020685ENSE00001127313chr4:155489533-155489646114FIBB_HUMAN240-278392B:210-248
E:210-248
39
39
2.6ENST000003020686ENSE00001127308chr4:155490334-155490459126FIBB_HUMAN278-320432B:248-290
E:248-290
43
43
2.7ENST000003020687ENSE00001127300chr4:155490666-155490951286FIBB_HUMAN320-415962B:290-385
E:290-385
96
96
2.8cENST000003020688cENSE00001171210chr4:155491571-155492238668FIBB_HUMAN415-491772B:385-458
E:385-458
74
74

3.1fENST000003360981fENSE00001820766chr4:155533800-155533684117FIBG_HUMAN1-26260--
3.2aENST000003360982aENSE00001781463chr4:155533587-15553354345FIBG_HUMAN27-41150--
3.2dENST000003360982dENSE00001624767chr4:155533353-155533170184FIBG_HUMAN42-103620--
3.2gENST000003360982gENSE00001652916chr4:155533050-15553295794FIBG_HUMAN103-134322C:97-108
F:97-108
12
12
3.3aENST000003360983aENSE00001127239chr4:155531349-155531219131FIBG_HUMAN134-178452C:108-152
F:108-152
45
45
3.3fENST000003360983fENSE00002146570chr4:155530915-155530782134FIBG_HUMAN178-222452C:152-196
F:152-196
45
45
3.4bENST000003360984bENSE00001127220chr4:155529802-155529618185FIBG_HUMAN223-284622C:197-258
F:197-258
62
62
3.5ENST000003360985ENSE00001127212chr4:155528134-155527857278FIBG_HUMAN284-377942C:258-351
F:258-351
94
94
3.6cENST000003360986cENSE00001344514chr4:155526218-155525728491FIBG_HUMAN377-453772C:351-397
F:351-397
47
47

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:74
 aligned with FIBA_HUMAN | P02671 from UniProtKB/Swiss-Prot  Length:866

    Alignment length:74
                                   147       157       167       177       187       197       207    
           FIBA_HUMAN   138 IEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIAKD 211
               SCOP domains d1fzca_ A: Fibrinogen alpha chain                                          SCOP domains
               CATH domains 1fzcA00 A:119-192  [code=1.20.5.50, no name defined]                       CATH domains
               Pfam domains -------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..............hhhhhhhhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) ----------------------S-----------------------W--------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------- PROSITE
               Transcript 1 Exon 1.4b  PDB: A:119-151        Exon 1.5b  PDB: A:152-192 [INCOMPLETE]    Transcript 1
                 1fzc A 119 IEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIAKD 192
                                   128       138       148       158       168       178       188    

Chain B from PDB  Type:PROTEIN  Length:308
 aligned with FIBB_HUMAN | P02675 from UniProtKB/Swiss-Prot  Length:491

    Alignment length:308
                                   190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480        
           FIBB_HUMAN   181 LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFF 488
               SCOP domains d1fzcb2 B:151-199 Fibrinogen beta chain          d1fzcb1 B:200-458 Fibrinogen C-terminal domains                                                                                                                                                                                                                     SCOP domains
               CATH domains 1fzcB03 B:151-201                                  1fzcB01 B:202-349,B:449-458 Gamma Fibrinogen, chain A, domain 1                                                                                     1fzcB02 B:350-448 Gamma-fibrinogen Carboxyl Terminal Fragment, domain 2                            1fzcB01    CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .........hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh................hhhhhh......eeeee........eeeee...hhh...eeeeee..........hhhhhheee.................eee.hhhhhhhhhh...eeeeeee.....eeeeee.eeee..hhh...eeee.eee....hhhh......hhhhhhh.....................................................................hhhh.......eeeeeee... Sec.struct. author
                 SAPs(SNPs) ---------------C-----Q--------------------------------------------------------------L---------------------------------------------------------------------------------------------------T-----------------R-----------------------K----------------------D-----------------------------------------------K---------- SAPs(SNPs)
                PROSITE (2) ---------------------------------------------------FIBRINOGEN_C_2  PDB: B:202-458 UniProt: 232-488                                                                                                                                                                                                                   PROSITE (2)
                PROSITE (1) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FIBRINOGEN_C_-------------------------------------------- PROSITE (1)
           Transcript 2 (1) Exon 2.4b  PDB: B:151-210 UniProt: 164-240 [INCOMPLETE]     -------------------------------------Exon 2.6  PDB: B:248-290 UniProt: 278-320  ----------------------------------------------------------------------------------------------Exon 2.8c  PDB: B:385-458 UniProt: 415-491 [INCOMPLETE]                    Transcript 2 (1)
           Transcript 2 (2) -----------------------------------------------------------Exon 2.5  PDB: B:210-248               -----------------------------------------Exon 2.7  PDB: B:290-385 UniProt: 320-415                                                       ------------------------------------------------------------------------- Transcript 2 (2)
                 1fzc B 151 LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFF 458
                                   160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450        

Chain C from PDB  Type:PROTEIN  Length:301
 aligned with FIBG_HUMAN | P02679 from UniProtKB/Swiss-Prot  Length:453

    Alignment length:301
                                   132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422 
           FIBG_HUMAN   123 EASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTIGEG 423
               SCOP domains d1fzcc2 C:97-141 Fibrinogen gamma chain      d1fzcc1 C:142-397 Fibrinogen C-terminal domains                                                                                                                                                                                                                  SCOP domains
               CATH domains 1fzcC03 C:97-143                               1fzcC01 C:144-286,C:381-391 Gamma Fibrinogen, chain A, domain 1                                                                                1fzcC02 C:287-380 Gamma-fibrinogen Carboxyl Terminal Fragment, domain 2                       1fzcC01    ------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..................hhhhh.......eeeee........eeeeeee.....eeeeeeee..........hhhhhh................hhhhhhhh......eeeeeeee.....eeeeeee......hhh................hhh.........hhhh.....................hhhhh.........................hhh......................eeeeeeee......... Sec.struct. author
             SAPs(SNPs) (1) -----------------H--------------------------------------------------R-------------------------------------------------------------------------------------------------------------C-P--------------V--------H------IDT--------D---------RV------K--------------------C----------------G--P-----V------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------H--------------------------------K---------------------Y--------------------------------------------W---------------------- SAPs(SNPs) (2)
                PROSITE (1) -----------------------------------------------FIBRINOGEN_C_2  PDB: C:144-390 UniProt: 170-416                                                                                                                                                                                                        ------- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
                PROSITE (3) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FIBRINOGEN_C_--------------------------------------------------- PROSITE (3)
           Transcript 3 (1) Exon 3.2g   -------------------------------------------Exon 3.3f  PDB: C:152-196 UniProt: 178-222   Exon 3.4b  PDB: C:197-258 UniProt: 223-284                    --------------------------------------------------------------------------------------------Exon 3.6c  PDB: C:351-397 UniProt: 377-453      Transcript 3 (1)
           Transcript 3 (2) -----------Exon 3.3a  PDB: C:108-152 UniProt: 134-178   ---------------------------------------------------------------------------------------------------------Exon 3.5  PDB: C:258-351 UniProt: 284-377                                                     ---------------------------------------------- Transcript 3 (2)
                 1fzc C  97 EASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTIGEG 397
                                   106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396 

Chain D from PDB  Type:PROTEIN  Length:74
 aligned with FIBA_HUMAN | P02671 from UniProtKB/Swiss-Prot  Length:866

    Alignment length:74
                                   147       157       167       177       187       197       207    
           FIBA_HUMAN   138 IEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIAKD 211
               SCOP domains d1fzcd_ D: Fibrinogen alpha chain                                          SCOP domains
               CATH domains 1fzcD00 D:119-192  [code=1.20.5.50, no name defined]                       CATH domains
               Pfam domains -------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..............hhhhhhhhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) ----------------------S-----------------------W--------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------- PROSITE
               Transcript 1 Exon 1.4b  PDB: D:119-151        Exon 1.5b  PDB: D:152-192 [INCOMPLETE]    Transcript 1
                 1fzc D 119 IEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIAKD 192
                                   128       138       148       158       168       178       188    

Chain E from PDB  Type:PROTEIN  Length:308
 aligned with FIBB_HUMAN | P02675 from UniProtKB/Swiss-Prot  Length:491

    Alignment length:308
                                   190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480        
           FIBB_HUMAN   181 LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFF 488
               SCOP domains d1fzce2 E:151-199 Fibrinogen beta chain          d1fzce1 E:200-458 Fibrinogen C-terminal domains                                                                                                                                                                                                                     SCOP domains
               CATH domains 1fzcE03 E:151-201                                  1fzcE01 E:202-349,E:449-458 Gamma Fibrinogen, chain A, domain 1                                                                                     1fzcE02 E:350-448 Gamma-fibrinogen Carboxyl Terminal Fragment, domain 2                            1fzcE01    CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .hhhh....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh................hhhhhh......eeeee........eeeee...hhh...eeeeee..........hhhhhheee.................eee.hhhhhhhhhh...eeeeeee.....eeeeee.eeee..hhh...eeee.eee....hhhh......hhhhhhh.....................................................................hhhh.......eeeeeee... Sec.struct. author
                 SAPs(SNPs) ---------------C-----Q--------------------------------------------------------------L---------------------------------------------------------------------------------------------------T-----------------R-----------------------K----------------------D-----------------------------------------------K---------- SAPs(SNPs)
                PROSITE (2) ---------------------------------------------------FIBRINOGEN_C_2  PDB: E:202-458 UniProt: 232-488                                                                                                                                                                                                                   PROSITE (2)
                PROSITE (1) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FIBRINOGEN_C_-------------------------------------------- PROSITE (1)
           Transcript 2 (1) Exon 2.4b  PDB: E:151-210 UniProt: 164-240 [INCOMPLETE]     -------------------------------------Exon 2.6  PDB: E:248-290 UniProt: 278-320  ----------------------------------------------------------------------------------------------Exon 2.8c  PDB: E:385-458 UniProt: 415-491 [INCOMPLETE]                    Transcript 2 (1)
           Transcript 2 (2) -----------------------------------------------------------Exon 2.5  PDB: E:210-248               -----------------------------------------Exon 2.7  PDB: E:290-385 UniProt: 320-415                                                       ------------------------------------------------------------------------- Transcript 2 (2)
                 1fzc E 151 LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFF 458
                                   160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450        

Chain F from PDB  Type:PROTEIN  Length:301
 aligned with FIBG_HUMAN | P02679 from UniProtKB/Swiss-Prot  Length:453

    Alignment length:301
                                   132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422 
           FIBG_HUMAN   123 EASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTIGEG 423
               SCOP domains d1fzcf2 F:97-141 Fibrinogen gamma chain      d1fzcf1 F:142-397 Fibrinogen C-terminal domains                                                                                                                                                                                                                  SCOP domains
               CATH domains 1fzcF03 F:97-143                               1fzcF01 F:144-286,F:381-391 Gamma Fibrinogen, chain A, domain 1                                                                                1fzcF02 F:287-380 Gamma-fibrinogen Carboxyl Terminal Fragment, domain 2                       1fzcF01    ------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..................hhhhhh......eeeee........eeeeeee.....eeeeeeee..........hhhhhh................hhhhhhhh......eeeeeeee.....eeeeeee................eeee.....hhh..................................hhhhh.........................hhh......................eeeeeeee......... Sec.struct. author
             SAPs(SNPs) (1) -----------------H--------------------------------------------------R-------------------------------------------------------------------------------------------------------------C-P--------------V--------H------IDT--------D---------RV------K--------------------C----------------G--P-----V------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------H--------------------------------K---------------------Y--------------------------------------------W---------------------- SAPs(SNPs) (2)
                PROSITE (1) -----------------------------------------------FIBRINOGEN_C_2  PDB: F:144-390 UniProt: 170-416                                                                                                                                                                                                        ------- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
                PROSITE (3) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FIBRINOGEN_C_--------------------------------------------------- PROSITE (3)
           Transcript 3 (1) Exon 3.2g   -------------------------------------------Exon 3.3f  PDB: F:152-196 UniProt: 178-222   Exon 3.4b  PDB: F:197-258 UniProt: 223-284                    --------------------------------------------------------------------------------------------Exon 3.6c  PDB: F:351-397 UniProt: 377-453      Transcript 3 (1)
           Transcript 3 (2) -----------Exon 3.3a  PDB: F:108-152 UniProt: 134-178   ---------------------------------------------------------------------------------------------------------Exon 3.5  PDB: F:258-351 UniProt: 284-377                                                     ---------------------------------------------- Transcript 3 (2)
                 1fzc F  97 EASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTIGEG 397
                                   106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396 

Chain G from PDB  Type:PROTEIN  Length:4
                                    
               SCOP domains ---- SCOP domains
               CATH domains ---- CATH domains
               Pfam domains ---- Pfam domains
         Sec.struct. author .... Sec.struct. author
                 SAPs(SNPs) ---- SAPs(SNPs)
                    PROSITE ---- PROSITE
                 Transcript ---- Transcript
                 1fzc G   1 GPRP   4

Chain H from PDB  Type:PROTEIN  Length:4
                                    
               SCOP domains ---- SCOP domains
               CATH domains ---- CATH domains
               Pfam domains ---- Pfam domains
         Sec.struct. author .... Sec.struct. author
                 SAPs(SNPs) ---- SAPs(SNPs)
                    PROSITE ---- PROSITE
                 Transcript ---- Transcript
                 1fzc H   1 GPRP   4

Chain I from PDB  Type:PROTEIN  Length:4
                                    
               SCOP domains ---- SCOP domains
               CATH domains ---- CATH domains
               Pfam domains ---- Pfam domains
         Sec.struct. author .... Sec.struct. author
                 SAPs(SNPs) ---- SAPs(SNPs)
                    PROSITE ---- PROSITE
                 Transcript ---- Transcript
                 1fzc I   1 GHRP   4

Chain J from PDB  Type:PROTEIN  Length:4
                                    
               SCOP domains ---- SCOP domains
               CATH domains ---- CATH domains
               Pfam domains ---- Pfam domains
         Sec.struct. author .... Sec.struct. author
                 SAPs(SNPs) ---- SAPs(SNPs)
                    PROSITE ---- PROSITE
                 Transcript ---- Transcript
                 1fzc J   1 GHRP   4

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (5, 10)

Asymmetric/Biological Unit

(-) CATH Domains  (3, 14)

Asymmetric/Biological Unit
(-)
Class: Alpha Beta (26913)
1a1fzcC01C:144-286,C:381-391
1b1fzcB01B:202-349,B:449-458
1c1fzcE01E:202-349,E:449-458
1d1fzcF01F:144-286,F:381-391

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 1FZC)

(-) Gene Ontology  (65, 151)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A,D   (FIBA_HUMAN | P02671)
molecular function
    GO:0050839    cell adhesion molecule binding    Interacting selectively and non-covalently with a cell adhesion molecule.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0030674    protein binding, bridging    The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0005198    structural molecule activity    The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.
biological process
    GO:0006953    acute-phase response    An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
    GO:0002250    adaptive immune response    An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0072377    blood coagulation, common pathway    A protein activation cascade that contributes to blood coagulation and consists of events leading from the formation of activated factor X to the formation of active thrombin, the cleavage of fibrinogen by thrombin, and the formation of cleaved fibrin into a stable multimeric, cross-linked complex.
    GO:0072378    blood coagulation, fibrin clot formation    A protein activation cascade that contributes to blood coagulation and consists of the cascade of enzymatic reactions initiated by physical damage to the wall of a blood vessel, leading to the formation of a formation of a fibrin clot at the site of the injury. The process also includes numerous positive and negative regulatory events.
    GO:0007160    cell-matrix adhesion    The binding of a cell to the extracellular matrix via adhesion molecules.
    GO:0043623    cellular protein complex assembly    The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell.
    GO:0044267    cellular protein metabolic process    The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
    GO:0071345    cellular response to cytokine stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
    GO:1990643    cellular response to granulocyte colony-stimulating factor    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a granulocyte colony-stimulating factor stimulus.
    GO:0071354    cellular response to interleukin-6    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-6 stimulus.
    GO:0071407    cellular response to organic cyclic compound    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
    GO:0030198    extracellular matrix organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
    GO:0042730    fibrinolysis    A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
    GO:0007599    hemostasis    The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
    GO:0002376    immune system process    Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
    GO:0043152    induction of bacterial agglutination    Any process in which infecting bacteria are clumped together by a host organism.
    GO:0045087    innate immune response    Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
    GO:0097421    liver regeneration    The regrowth of lost or destroyed liver.
    GO:2000261    negative regulation of blood coagulation, common pathway    Any process that stops, prevents or reduces the frequency, rate or extent of blood coagulation, common pathway.
    GO:2000352    negative regulation of endothelial cell apoptotic process    Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
    GO:1902042    negative regulation of extrinsic apoptotic signaling pathway via death domain receptors    Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
    GO:0031639    plasminogen activation    The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.
    GO:0030168    platelet activation    A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
    GO:0070527    platelet aggregation    The adhesion of one platelet to one or more other platelets via adhesion molecules.
    GO:0002576    platelet degranulation    The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
    GO:0070374    positive regulation of ERK1 and ERK2 cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0045921    positive regulation of exocytosis    Any process that activates or increases the frequency, rate or extent of exocytosis.
    GO:0034116    positive regulation of heterotypic cell-cell adhesion    Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
    GO:0090277    positive regulation of peptide hormone secretion    Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
    GO:0050714    positive regulation of protein secretion    Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
    GO:1900026    positive regulation of substrate adhesion-dependent cell spreading    Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
    GO:0045907    positive regulation of vasoconstriction    Any process that activates or increases the frequency, rate or extent of vasoconstriction.
    GO:0006461    protein complex assembly    The aggregation, arrangement and bonding together of a set of components to form a protein complex.
    GO:0051258    protein polymerization    The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein.
    GO:0051592    response to calcium ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
    GO:0046898    response to cycloheximide    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cycloheximide stimulus. Cycloheximide (actidione) is an antibiotic produced by some Streptomyces species which interferes with protein synthesis in eukaryotes.
    GO:0032355    response to estradiol    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
    GO:0033595    response to genistein    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a genistein stimulus.
    GO:0043278    response to morphine    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a morphine stimulus. Morphine is an opioid alkaloid, isolated from opium, with a complex ring structure.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
cellular component
    GO:0072562    blood microparticle    A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
    GO:0005938    cell cortex    The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0009897    external side of plasma membrane    The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:1903561    extracellular vesicle    Any vesicle that is part of the extracellular region.
    GO:0005577    fibrinogen complex    A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0031091    platelet alpha granule    A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
    GO:0031093    platelet alpha granule lumen    The volume enclosed by the membrane of the platelet alpha granule.
    GO:0005791    rough endoplasmic reticulum    The rough (or granular) endoplasmic reticulum (ER) has ribosomes adhering to the outer surface; the ribosomes are the site of translation of the mRNA for those proteins which are either to be retained within the cisternae (ER-resident proteins), the proteins of the lysosomes, or the proteins destined for export from the cell. Glycoproteins undergo their initial glycosylation within the cisternae.

Chain B,E   (FIBB_HUMAN | P02675)
molecular function
    GO:0050839    cell adhesion molecule binding    Interacting selectively and non-covalently with a cell adhesion molecule.
    GO:0051087    chaperone binding    Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0030674    protein binding, bridging    The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0005198    structural molecule activity    The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.
biological process
    GO:0002250    adaptive immune response    An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0072378    blood coagulation, fibrin clot formation    A protein activation cascade that contributes to blood coagulation and consists of the cascade of enzymatic reactions initiated by physical damage to the wall of a blood vessel, leading to the formation of a formation of a fibrin clot at the site of the injury. The process also includes numerous positive and negative regulatory events.
    GO:0007160    cell-matrix adhesion    The binding of a cell to the extracellular matrix via adhesion molecules.
    GO:0043623    cellular protein complex assembly    The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell.
    GO:0071347    cellular response to interleukin-1    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
    GO:0044320    cellular response to leptin stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism.
    GO:0030198    extracellular matrix organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
    GO:0042730    fibrinolysis    A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
    GO:0007599    hemostasis    The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
    GO:0002376    immune system process    Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
    GO:0043152    induction of bacterial agglutination    Any process in which infecting bacteria are clumped together by a host organism.
    GO:0045087    innate immune response    Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
    GO:2000352    negative regulation of endothelial cell apoptotic process    Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
    GO:1902042    negative regulation of extrinsic apoptotic signaling pathway via death domain receptors    Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
    GO:0031639    plasminogen activation    The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.
    GO:0030168    platelet activation    A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
    GO:0070527    platelet aggregation    The adhesion of one platelet to one or more other platelets via adhesion molecules.
    GO:0002576    platelet degranulation    The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
    GO:0070374    positive regulation of ERK1 and ERK2 cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0045921    positive regulation of exocytosis    Any process that activates or increases the frequency, rate or extent of exocytosis.
    GO:0034116    positive regulation of heterotypic cell-cell adhesion    Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
    GO:0090277    positive regulation of peptide hormone secretion    Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
    GO:0050714    positive regulation of protein secretion    Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
    GO:1900026    positive regulation of substrate adhesion-dependent cell spreading    Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
    GO:0045907    positive regulation of vasoconstriction    Any process that activates or increases the frequency, rate or extent of vasoconstriction.
    GO:0051258    protein polymerization    The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein.
    GO:0051592    response to calcium ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
cellular component
    GO:0072562    blood microparticle    A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
    GO:0005938    cell cortex    The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0009897    external side of plasma membrane    The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:1903561    extracellular vesicle    Any vesicle that is part of the extracellular region.
    GO:0005577    fibrinogen complex    A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0031091    platelet alpha granule    A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
    GO:0031093    platelet alpha granule lumen    The volume enclosed by the membrane of the platelet alpha granule.

Chain C,F   (FIBG_HUMAN | P02679)
molecular function
    GO:0050839    cell adhesion molecule binding    Interacting selectively and non-covalently with a cell adhesion molecule.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0030674    protein binding, bridging    The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0005198    structural molecule activity    The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.
biological process
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0072378    blood coagulation, fibrin clot formation    A protein activation cascade that contributes to blood coagulation and consists of the cascade of enzymatic reactions initiated by physical damage to the wall of a blood vessel, leading to the formation of a formation of a fibrin clot at the site of the injury. The process also includes numerous positive and negative regulatory events.
    GO:0007160    cell-matrix adhesion    The binding of a cell to the extracellular matrix via adhesion molecules.
    GO:0043623    cellular protein complex assembly    The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell.
    GO:0030198    extracellular matrix organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
    GO:0042730    fibrinolysis    A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
    GO:0007599    hemostasis    The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
    GO:2000352    negative regulation of endothelial cell apoptotic process    Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
    GO:1902042    negative regulation of extrinsic apoptotic signaling pathway via death domain receptors    Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
    GO:0031639    plasminogen activation    The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.
    GO:0030168    platelet activation    A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
    GO:0070527    platelet aggregation    The adhesion of one platelet to one or more other platelets via adhesion molecules.
    GO:0002576    platelet degranulation    The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
    GO:0070374    positive regulation of ERK1 and ERK2 cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0045921    positive regulation of exocytosis    Any process that activates or increases the frequency, rate or extent of exocytosis.
    GO:0034116    positive regulation of heterotypic cell-cell adhesion    Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
    GO:0090277    positive regulation of peptide hormone secretion    Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
    GO:0050714    positive regulation of protein secretion    Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
    GO:1900026    positive regulation of substrate adhesion-dependent cell spreading    Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
    GO:0045907    positive regulation of vasoconstriction    Any process that activates or increases the frequency, rate or extent of vasoconstriction.
    GO:0051258    protein polymerization    The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein.
    GO:0009306    protein secretion    The controlled release of proteins from a cell.
    GO:0051592    response to calcium ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
cellular component
    GO:0072562    blood microparticle    A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
    GO:0005938    cell cortex    The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0009897    external side of plasma membrane    The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005577    fibrinogen complex    A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0031091    platelet alpha granule    A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
    GO:0031093    platelet alpha granule lumen    The volume enclosed by the membrane of the platelet alpha granule.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    CA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    MAN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Arg B:406 - Cys B:407   [ RasMol ]  
    Arg E:406 - Cys E:407   [ RasMol ]  
    Lys C:338 - Cys C:339   [ RasMol ]  
    Lys F:338 - Cys F:339   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1fzc
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  FIBA_HUMAN | P02671
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  FIBB_HUMAN | P02675
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  FIBG_HUMAN | P02679
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  202400
    Disease InformationOMIM
  616004
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  FIBA_HUMAN | P02671
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  FIBB_HUMAN | P02675
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  FIBG_HUMAN | P02679
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        FIBA_HUMAN | P026711bbr 1dm4 1fph 1fza 1fzb 1fzd 1fze 1fzf 1fzg 1lt9 1ltj 1n86 1n8e 1re3 1re4 1rf0 1rf1 1ycp 2a45 2ffd 2h43 2hlo 2hod 2hpc 2oyh 2oyi 2q9i 2xnx 2xny 2z4e 3at0 3bvh 3e1i 3ghg 3h32 3hus 4f27 5cfa
        FIBB_HUMAN | P026751fza 1fzb 1fze 1fzf 1fzg 1lt9 1ltj 1n86 1n8e 1re3 1re4 1rf0 1rf1 2a45 2ffd 2h43 2hlo 2hod 2hpc 2oyh 2oyi 2q9i 2xnx 2xny 2z4e 3bvh 3e1i 3ghg 3h32 3hus
        FIBG_HUMAN | P026791dug 1fib 1fic 1fid 1fza 1fzb 1fze 1fzf 1fzg 1lt9 1ltj 1n86 1n8e 1re3 1re4 1rf0 1rf1 2a45 2ffd 2fib 2h43 2hlo 2hod 2hpc 2hwl 2oyh 2oyi 2q9i 2vdo 2vdp 2vdq 2vdr 2vr3 2xnx 2xny 2y7l 2z4e 3bvh 3e1i 3fib 3ghg 3h32 3hus 4b60

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 1FZC)